A randomized controlled clinical study on the effect of moxibustion on the quality of life in patients with gastric cancer

Hebei University of Chinese Meidicne0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1.Patients who meet the Chinese Society of Clinical Oncology (CSCO) Guidelines for Diagnosis and Treatment of Gastric Cancer (2018.V1) diagnosed as gastric cancer by cytology or histopathology;
•2.According to the American Joint Committee on Cancer (AJCC) / The Union for International Cancer Control (UICC) gastric cancer TNM staging system (8th edition), patients who with gastric cancer in stage II, III and IV;
•3.Patients whose inspection indicators are in line with chemotherapy indications and undergoing in chemotherapy treatment;
•4.The patients age from 18 to 70 years old, regardless of gender;
•5.KPS score is over 60;
•6.The estimated survival time is not less than 3 months through symptoms, signs and other auxiliary examinations;
•7.The patients have good compliance, understand the real situation of this study, participate voluntarily, and sign the informed consent.

•1.Patients in perioperative preoperative chemotherapy
•2.Pregnant or lactating women;
•3..Patients with severe hepatic and renal dysfunction,or combined with severe cardiovascular and cerebrovascular diseases, diabetes, infectious diseases, etc., with obvious bleeding tendency;
•4.Patients with poor compliance, or mental disorders cannot cooperate with treatment;
•5.Patients have been accepted other therapeutic measures similar to this study, which may interfere with or affect the observation indicators of this trial.

发起方

Hebei University of Chinese Meidicne